Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Oran

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Bone Marrow Transplantation|May 24, 2011
Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donorsN S Majhail, C G Brunstein, R Shanley, et al.
Bone Marrow Transplantation|July 5, 2006
Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapyH J Lee, B Oran, R M Saliba, et al.
Bone Marrow Transplantation|August 13, 2013
Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AMLC Ustun, A C Wiseman, T E Defor, et al.
Bone Marrow Transplantation|November 18, 2008
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AMLR M Saliba, K V Komanduri, S Giralt, et al.
Bone Marrow Transplantation|June 4, 2015
Umbilical cord blood graft engineering: challenges and opportunitiesP A Thompson, K Rezvani, C M Hosing, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 27, 2015
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell RecipientsA Abudayyeh, A Hamdi, H Lin, et al.
Bone Marrow Transplantation|September 6, 2016
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLLI F Khouri, D Sui, E J Jabbour, et al.
Leukemia|August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseV Bachanova, D I Marks, M-J Zhang, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Bone Marrow Transplantation|May 24, 2011
Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donorsN S Majhail, C G Brunstein, R Shanley, et al.
Bone Marrow Transplantation|July 5, 2006
Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapyH J Lee, B Oran, R M Saliba, et al.
Bone Marrow Transplantation|August 13, 2013
Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AMLC Ustun, A C Wiseman, T E Defor, et al.
Bone Marrow Transplantation|November 18, 2008
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AMLR M Saliba, K V Komanduri, S Giralt, et al.
Bone Marrow Transplantation|June 4, 2015
Umbilical cord blood graft engineering: challenges and opportunitiesP A Thompson, K Rezvani, C M Hosing, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 27, 2015
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell RecipientsA Abudayyeh, A Hamdi, H Lin, et al.
Bone Marrow Transplantation|September 6, 2016
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLLI F Khouri, D Sui, E J Jabbour, et al.
Leukemia|August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseV Bachanova, D I Marks, M-J Zhang, et al.
Pageof 3